NS-LIJ docs to the rescue with new heart pump
North Shore-LIJ doctors saved the life of a 74-year-old patient late last month using a tiny motorized device – just approved by the FDA – that boosts heart function in…
Biotech
Stony Brook startup gets $100K seed investment
By GREGORY ZELLER Investment partners Accelerate Long Island and the Long Island Emerging Technologies Fund announced a $100,000 infusion into Right Dose Inc., a high-tech startup borne from research conducted…
Codagenix gets $100K USDA grant for Foot and Mouth vaccine
By GREGORY ZELLER // Codagenix, the Stony Brook biotech startup, has been awarded a $100,000 federal grant to develop a vaccine for the infectious Foot and Mouth Disease Virus. Funding…
Feinstein eyes $400M center for bioelectronic med
By GREGORY ZELLER // Hundreds of millions of dollars, 250,000 square feet, dozens of laboratories and one throbbing center at the heart of a reinvigorated Long Island economy. Yep. Kevin…
Feinstein’s vagus research takes plenty of nerve
BY GREGORY ZELLER // What happens in vagus doesn’t actually stay there. Or at least that’s the theory behind electrical stimulation of the vagus nerve, a long cranial bundle that…
In tattoo removal, it’s all about thinking backwards
By GREGORY ZELLER // If you’ve ever wanted a tattoo but balked at that whole, you know, forever thing, hang on. Joseph Miccio is back at the drawing board. In…
Leading the fight against C. Diff
By GREGORY ZELLER // Researchers battling the insidious clostridium difficile infection are making progress on several new fronts, including a novel “poop pill” developed by Symbiotic Health, a spinoff from North…
Serious brain drain: When CSHL considered leaving
Cold Spring Harbor Lab officials considered moving the facility off Long Island in 1948 due to transportation concerns and the fact that local life was not very “rich.” At the…
Goddard Labs snags biotech honor
Goddard Labs, a Calverton-based startup that has developed breakthrough food and water testing technology, has been named Best in Show of the Mid Atlantic Bio Angels’ 1st Pitch Life Sciences…
CSHL plans new center to push research to market
BY JOHN L. KOMINICKI // Cold Spring Harbor Laboratory plans a $75 million therapeutic research center that would help speed to market treatments for cancer, autism and other diseases without…
Traverse Biosciences inks R&D, licensing deal
BY GREGORY ZELLER // Stony Brook-based startup Traverse Biosciences has inked an exclusive R&D agreement that could lead to an $8 million sublicensing option. Traverse, a resident of the Long…
Traverse readies the move to market
BY GREGORY ZELLER // Armed with a just-executed licensing agreement for a suite of anti-inflammatory drug therapies, two-year-old Traverse Biosciences is stepping up efforts to land the investors and strategic…
Watson makes $1M CSHL gift
A million-dollar donation to Cold Spring Harbor Laboratory? Doctor Watson, we presume. And that presumption, of course, is correct: CSHL Chancellor Emeritus James Watson and his wife, Liz, have done…
Feinstein partnering with Australian pharma
The Feinstein Institute for Medical Research has inked a partnership deal with Novogen, an Australian pharmaceuticals giant and parent company of San Diego-based MEI Pharma, which produces a growing list…
Sticking it to the Man
By GREGORY ZELLER // Katarzyna Sawicka has authority issues. Not that you can really blame her. Ever since she was an undergrad at Stony Brook University, she was told her…